MetLife Investment Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,416
| Closed | -$83.7K | – | 2938 |
|
|
2023
Q2 | $83.7K | Buy |
3,416
+1,609
| +89% | +$39.4K | ﹤0.01% | 2795 |
|
|
2023
Q1 | $56.5K | Sell |
1,807
-1,002
| -36% | -$31.4K | ﹤0.01% | 2706 |
|
|
2022
Q4 | $198K | Hold |
2,809
| – | – | ﹤0.01% | 2249 |
|
|
2022
Q3 | $242K | Buy |
2,809
+795
| +39% | +$68.5K | ﹤0.01% | 2158 |
|
|
2022
Q2 | $167K | Hold |
2,014
| – | – | ﹤0.01% | 2439 |
|
|
2022
Q1 | $335K | Buy |
2,014
+720
| +56% | +$120K | ﹤0.01% | 2029 |
|
|
2021
Q4 | $216K | Hold |
1,294
| – | – | ﹤0.01% | 2004 |
|
|
2021
Q3 | $112K | Buy |
+1,294
| New | +$112K | ﹤0.01% | 2395 |
|
|
2019
Q3 | – | Sell |
-694
| Closed | -$53.5K | – | 2363 |
|
|
2019
Q2 | $53.5K | Hold |
694
| – | – | ﹤0.01% | 2413 |
|
|
2019
Q1 | $123K | Buy |
+694
| New | +$123K | ﹤0.01% | 2234 |
|